IVF
Price
$1.02
Change
-$0.02 (-1.92%)
Updated
Jul 20, 04:59 PM (EDT)
Capitalization
1.86M
24 days until earnings call
Intraday BUY SELL Signals
RANI
Price
$0.69
Change
-$0.01 (-1.43%)
Updated
Jul 20, 04:59 PM (EDT)
Capitalization
78.37M
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IVF vs RANI

IVF vs RANI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IVF vs. RANI commentary
Jul 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVF is a Hold and RANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2026
Stock price -- (IVF: $1.04 vs. RANI: $0.70)
Brand notoriety: IVF and RANI are both not notable
IVF represents the Medical/Nursing Services, while RANI is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVF: 2% vs. RANI: 79%
Market capitalization -- IVF: $1.86M vs. RANI: $78.37M
IVF [@Medical/Nursing Services] is valued at $1.86M. RANI’s [@Biotechnology] market capitalization is $78.37M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $175.37B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $123.26B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVF’s FA Score shows that 1 FA rating(s) are green whileRANI’s FA Score has 1 green FA rating(s).

  • IVF’s FA Score: 1 green, 4 red.
  • RANI’s FA Score: 1 green, 4 red.
According to our system of comparison, RANI is a better buy in the long-term than IVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVF’s TA Score shows that 1 TA indicator(s) are bullish while RANI’s TA Score has 5 bullish TA indicator(s).

  • IVF’s TA Score: 1 bullish, 7 bearish.
  • RANI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RANI is a better buy in the short-term than IVF.

Price Growth

IVF (@Medical/Nursing Services) experienced а -7.96% price change this week, while RANI (@Biotechnology) price change was +1.47% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.57%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was -19.86%.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.08%. For the same industry, the average monthly price growth was +1.65%, and the average quarterly price growth was +1892.03%.

Reported Earning Dates

IVF is expected to report earnings on Aug 13, 2026.

RANI is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Medical/Nursing Services (-3.57% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Biotechnology (-2.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RANI($78.4M) has a higher market cap than IVF($1.86M). RANI YTD gains are higher at: -48.348 vs. IVF (-72.362). IVF has higher annual earnings (EBITDA): -9.34M vs. RANI (-33.38M). RANI has more cash in the bank: 43.4M vs. IVF (356K). RANI has less debt than IVF: RANI (3.94M) vs IVF (4.23M). IVF has higher revenues than RANI: IVF (6.94M) vs RANI (3.17M).
IVFRANIIVF / RANI
Capitalization1.86M78.4M2%
EBITDA-9.34M-33.38M28%
Gain YTD-72.362-48.348150%
P/E Ratio0.00N/A-
Revenue6.94M3.17M219%
Total Cash356K43.4M1%
Total Debt4.23M3.94M107%
FUNDAMENTALS RATINGS
IVF: Fundamental Ratings
IVF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IVFRANI
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IVF
Daily Signal:
Gain/Loss:
RANI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCO168.47-0.20
-0.12%
Ducommun
RPM105.08-1.23
-1.16%
RPM International
NGS38.77-0.84
-2.12%
Natural Gas Services Group
FSI5.94-0.13
-2.22%
Flexible Solutions International
AEMD0.65-0.02
-3.39%
Aethlon Medical Inc.

IVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVF has been closely correlated with INBS. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVF jumps, then INBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVF
1D Price
Change %
IVF100%
-7.96%
INBS - IVF
77%
Closely correlated
-2.73%
VNDA - IVF
40%
Loosely correlated
-0.18%
IVA - IVF
30%
Poorly correlated
+2.21%
RANI - IVF
30%
Poorly correlated
+4.09%
IRD - IVF
27%
Poorly correlated
-0.30%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with ARTV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
+4.09%
ARTV - RANI
45%
Loosely correlated
+7.96%
ARMP - RANI
44%
Loosely correlated
+19.95%
ACHV - RANI
41%
Loosely correlated
+5.20%
IRON - RANI
37%
Loosely correlated
+3.65%
VYGR - RANI
32%
Poorly correlated
+4.28%
More